Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Chinese Patent Office
Johnson and Johnson
US Department of Justice
Fish and Richardson
Express Scripts
McKesson
Cantor Fitzgerald
Boehringer Ingelheim

Generated: November 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022116

« Back to Dashboard

NDA 022116 describes LEXIVA, which is a drug marketed by Viiv Hlthcare and is included in two NDAs. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the LEXIVA profile page.

The generic ingredient in LEXIVA is fosamprenavir calcium. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the fosamprenavir calcium profile page.
Summary for 022116
Tradename:LEXIVA
Applicant:Viiv Hlthcare
Ingredient:fosamprenavir calcium
Patents:1
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 022116
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEXIVA fosamprenavir calcium SUSPENSION;ORAL 022116 NDA ViiV Healthcare Company 49702-208 49702-208-53 225 mL in 1 BOTTLE (49702-208-53)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrengthEQ 50MG BASE/ML
Approval Date:Jun 14, 2007TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Jun 24, 2018Product Flag?Substance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Queensland Health
Colorcon
Healthtrust
Accenture
Teva
Cipla
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.